As of 4:00pm ET
| +6.21 / +2.07%|
The 6 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 306.50, with a high estimate of 400.00 and a low estimate of 300.00. The median estimate represents a +0.04% increase from the last price of 306.37.
The current consensus among 7 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.